Adjuvant therapy in breast cancer.
Adjuvant therapy has a positive impact in both premenopausal and postmenopausal women with primary breast cancer. Some general principles can be used in making treatment decisions; however, the precise role of adjuvant treatment in breast cancer remains unclear in most clinical settings. Prognostic factors are discussed, along with information on uses of chemotherapy and tamoxifen.
Robert
N J
NJ
Section of Hematology/Oncology, Fairfax Hospital, Falls Church, Virginia, USA.
D000328:Adult; D000465:Algorithms; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D010052:Ovariectomy; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen